CN104027764A - Medicine for treating rheumatoid bone diseases - Google Patents

Medicine for treating rheumatoid bone diseases Download PDF

Info

Publication number
CN104027764A
CN104027764A CN201410255761.1A CN201410255761A CN104027764A CN 104027764 A CN104027764 A CN 104027764A CN 201410255761 A CN201410255761 A CN 201410255761A CN 104027764 A CN104027764 A CN 104027764A
Authority
CN
China
Prior art keywords
radix
rhizoma
medicine
root
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410255761.1A
Other languages
Chinese (zh)
Inventor
张元正
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410255761.1A priority Critical patent/CN104027764A/en
Publication of CN104027764A publication Critical patent/CN104027764A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a medicine for treating rheumatoid bone diseases, which is prepared by comprising the following steps: by taking notopterygium root, radix angelicae pubescentis, radix clematidis, rhizoma corydalis, fraxinus bungeana, teasel root, asarum, rhizoma zingiberis, astragalus membranaceus, medicinal cyathula root, the root of red-rooted salvia, centipede, lumbricus, pawpaw, aplotaxis auriculata, rheum officinale, bighead atractylodes rhizome, radix bupleuri, cassia twig, the bark of eucommia, liquorice, medicated leaven, caulis spatholobi and poria cocos as the raw materials, drying, crushing, and preparing powder, capsules or pills. For treating the diseases, such as rheumatoid bone diseases, the medicine disclosed by the invention has the effects of diminishing inflammation, relieving pain, relaxing tendons, activating collaterals, promoting blood circulation, removing stasis, softening spur and the like and has the outstanding characteristics of resolving both symptoms and root causes and being good in long-term effect.

Description

The medicine for the treatment of rheumatic osteopathia
Technical field
The present invention relates to field of medicaments, a kind of Chinese patent medicine for the treatment of rheumatic osteopathia that the Chinese herbal medicine of specifically take is prepared as raw material.
Background technology
Rheumatism, rheumatoid, prolapse of lumbar intervertebral disc, hyperosteogeny, sciatica, ankylosing spondylitis, cervical spondylosis, scapulohumeral periarthritis, arthritis, gout, hemiplegia etc. are all commonly encountered diseases, frequently-occurring disease, during morbidity, patient shows as local pain, swollen, numb, the limitation of activity of acid, red and swollen heating, and when serious, nerve compression can shadow play amyotrophy and paralyses.At present, the medicine for the treatment of above-mentioned disease is a lot, as FENGTONGNING capsule, Cao Qinghua rheumatism capsule, Radix Notoginseng rheumatism capsule etc., has his own strong points, though effectively cure the symptoms, not the disease.
 
Summary of the invention
The object of the present invention is to provide a kind of have take stopgap measures and effect a permanent cure, the medicine of the treatment rheumatic osteopathia that late result is good.
The present invention's adopted technical scheme of dealing with problems is: a kind of medicine for the treatment of rheumatic osteopathia, and it is to be made by the raw material of following weight parts:
Rhizoma Et Radix Notopterygii 5-20 Radix Angelicae Pubescentis 5-20 Radix Clematidis 5-25 Rhizoma Corydalis 5-10
Radix Gentianae Macrophyllae 5-10 Radix Dipsaci 5-15 Herba Asari 5-6 Rhizoma Zingiberis 5-12
Radix Astragali 5-30 Radix Cyathulae 5-20 Radix Salviae Miltiorrhizae 5-10 Scolopendra 5-10
Pheretima 5-10 Fructus Chaenomelis 5-10 Saussurea lappa Clarke 5-10 Radix Et Rhizoma Rhei 5-12
Rhizoma Atractylodis Macrocephalae 5-10 Radix Bupleuri 5-10 Ramulus Cinnamomi 5-10 Cortex Eucommiae 5-15
Radix Glycyrrhizae 5-10 Massa Medicata Fermentata 5-8 Caulis Spatholobi 5-8 Poria 5-10
The medicine of described treatment rheumatic osteopathia, it is to be made by the raw material of following weight parts:
Rhizoma Et Radix Notopterygii 20 Radix Angelicae Pubescentis 20 Radix Clematidis 25 Rhizoma Corydalis 10
Radix Gentianae Macrophyllae 10 Radix Dipsaci 15 Herba Asari 6 Rhizoma Zingiberiss 12
The Radix Astragali 30 Radix Cyathulae 20 Radix Salviae Miltiorrhizae 10 Scolopendras 10
Pheretima 10 Fructus Chaenomelis 10 Saussurea lappa Clarke 10 Radix Et Rhizoma Rhei 12
The Rhizoma Atractylodis Macrocephalae 10 Radix Bupleuri 10 Ramulus Cinnamomi 10 Cortexs Eucommiae 15
Radix Glycyrrhizae 10 Massa Medicata Fermentata 8 Caulis Spatholobi 8 Poria 10
Said medicine is said dosage form on any pharmaceutics.
Said medicament is powder or piece agent.
Technical scheme of the present invention is mechanism understanding and the Therapeutic Principle to cards such as rheumatism, rheumatoid, prolapse of lumbar intervertebral disc, hyperosteogeny, sciatica, scapulohumeral periarthritis, arthritis, gout, hemiplegias based on motherland's medical science, with reference to modern pharmacological research, achieve, from Chinese herbal medicine, filter out the natural edible-plant medicine of anti-inflammatory analgetic, blood circulation promoting and blood stasis dispelling, the softening bony spur of dredging collateral and surrounding soft tissue's righting, by theory of Chinese medical science folk prescription, the body resistance strengthening and constitution consolidating, enhancing human body immunity function, reaches the object for the treatment of both the principal and secondary aspects of a disease.
In side of the present invention, pungent, the bitter temperature of Rhizoma Et Radix Notopterygii nature and flavor, relieving the exterior syndrome by diaphoresis, dispels the wind and overcomes the coldness; Radix Angelicae Pubescentis nature and flavor are arduous, the expelling wind and dampness pain relieving of overflowing, and cold expelling induces sweat; Radix Clematidis nature and flavor are pungent, salty, flat, poisonous, and expelling wind and removing dampness, by drink removing food stagnancy; Warm in nature, the Huoxue San " promoting the circulation of QI pain relieving of working hard of Rhizoma Corydalis nature and flavor; Radix Gentianae Macrophyllae nature and flavor are bitter, pungent tepor, wind-expelling pain-stopping, clearing away heat and promoting diuresis; Radix Dipsaci nature and flavor toil is sweet wet, wind-damp dispelling bone and muscle strengthening, tonifying kidney for preventing miscarriage; Herba Asari nature and flavor toil temperature, expelling pathogenic wind from the body surface, dispersing cold for relieving pain, warming the lung to resolve fluid-retention; The hot warming middle-JIAO recuperating depleted YANG of Rhizoma Zingiberis nature and flavor, warming the lung to resolve fluid-retention, warming the meridian for stopping bleeding; The sweet tepor of Radix Astragali nature and flavor, tonifying Qi and lifting yang, strengthening superficial resistance to stop perspiration, holder skin ulcer granulation promoting; The sweet micro-hardship of Radix Cyathulae nature and flavor acid is flat, and removing blood stasis stimulates the menstrual flow, strong muscular rheumatism; Radix Salviae Miltiorrhizae nature and flavor hardship is slightly cold, blood circulation promoting and blood stasis dispelling, removing heat from blood mind calming; Scolopendra property and flavor of peppery and warm is poisonous, endogenous wind stopping relieving convulsion, the eliminating stagnation of inducing sweat; Pheretima nature and flavor are salty-cold, heat clearing away relieving convulsion, dredge the meridian passage, clearing lung, relieving asthma, inducing diuresis for treating stranguria syndrome; Fructus Chaenomelis nature and flavor acid temperature, relaxing muscles and tendons and activating QI and blood in the collateral, removing dampness for regulating stomach; The bitter temperature of Saussurea lappa Clarke nature and flavor, promoting the circulation of QI to relieve pain; Radix Et Rhizoma Rhei nature and flavor bitter cold, stasis removing, eliminating fire and detoxication; Rhizoma Atractylodis Macrocephalae nature and flavor sweetness and bitterness temperature, invigorating the spleen and replenishing QI, dampness diuretic, strengthening superficial resistance to stop perspiration; Radix Bupleuri mildly bitter flavor is slightly cold, and loose heresy is induced sweat, relieving depressed liver and clearing heat, ascending up spleen-Qi and Yang; Ramulus Cinnamomi acrid-sweet flavor temperature, expelling pathogenic factors from muscles by diaphoresis, warming YANG pain relieving; The sweet micro-pungent temperature of Cortex Eucommiae nature and flavor, invigorating the liver and kidney, bone and muscle strengthening, warm palace is antiabortive; Radix Glycyrrhizae nature and flavor are sweet flat, QI invigorating invigorating middle warmer, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, the mediation property of medicine; Massa Medicata Fermentata nature and flavor Gan Xinwen, the stomach function regulating that helps digestion, blood-activating analgetic; Caulis Spatholobi property bitter but slightly sweet taste temperature, enriches blood and invigorates blood circulation; Poria slightly sweet flavor is flat, promoting diuresis to eliminate damp pathogen, spleen invigorating invigorating middle warmer, mind tranquilizing and the heart calming.
Advantage of the present invention is: nontoxic non-evident effect; after taking medicine 24 hours, promoting blood circulation to remove obstruction in the collateral, anti-inflammatory analgetic, detumescence, facilitating digestion, appetite strengthen; the most outstanding feature is treating both the principal and secondary aspects of a disease; long-term effect is good; in clinical, many patients can participate in normal activity in one week or 30 days taking this medicine as rheumatism paralysis 2-10; so far not recurrence, rheumatic osteopathia patient long-term taking is conducive to healthy and thoroughly cures.Indivedual patients take after 5 days and occur constipation, within 5 days, recover afterwards normal, the patient of serious gastric ulcer and gastrorrhagia be can not take more or prohibit clothes, to suffering from the careful clothes of patient or the disobediences such as serious hypertension, heart disease, pulmonary tuberculosis, diabetic complication.
For the therapeutic effect of proof medicine of the present invention to patient, the present invention is through 1036 routine clinical observations, from being in hospital and outpatient service selection case, diagnostic criteria is: joint deformity, cervical vertebra are ached, lumbar vertebra pain, sciatica and red and swollen heating, difficulty in walking or paralysis, X-ray, CT scan, nuclear-magnetism supply to shake and anti-O, erythrocyte sedimentation rate chemical examination are respectively: rheumatoid, intervertebral disk hernia, degeneration and gouty arthritis etc.Medical history 5 years is with interior 756 examples, 5-10 212 examples, 4 years above 68 examples, and treatment criterion is: cure, take medicine 1-2 the course for the treatment of transference cure, in drug withdrawal 3-5, do not recur; Take a turn for the better: the symptom of taking medicine in latter 24 hours-15 days has obviously and alleviates; Invalid: the 5 days symptoms of taking medicine are without alleviating, and the instructions of taking of this medicine: 8-16 gram/times, day take 2-3 time; Boiled water is taken after mixing it with water after meal, and concrete condition is in Table 1 table 2.
Table 1 patient situation statistics
Take medicine curative effect statistics of table 2
The specific embodiment
Basic components of the present invention is as follows: (following formula is weight proportion)
Rhizoma Et Radix Notopterygii 5-20 Radix Angelicae Pubescentis 5-20 Radix Clematidis 5-25 Rhizoma Corydalis 5-10
Radix Gentianae Macrophyllae 5-10 Radix Dipsaci 5-15 Herba Asari 5-6 Rhizoma Zingiberis 5-12
Radix Astragali 5-30 Radix Cyathulae 5-20 Radix Salviae Miltiorrhizae 5-10 Scolopendra 5-10
Pheretima 5-10 Fructus Chaenomelis 5-10 Saussurea lappa Clarke 5-10 Radix Et Rhizoma Rhei 5-12
Rhizoma Atractylodis Macrocephalae 5-10 Radix Bupleuri 5-10 Ramulus Cinnamomi 5-10 Cortex Eucommiae 5-15
Radix Glycyrrhizae 5-10 Massa Medicata Fermentata 5-8 Caulis Spatholobi 5-8 Poria 5-10.
Formula 1:
Rhizoma Et Radix Notopterygii 20 Radix Angelicae Pubescentis 20 Radix Clematidis 25 Rhizoma Corydalis 10 Radix Gentianae Macrophyllae 10 Radix Dipsaci 15 Herba Asari 6 Rhizoma Zingiberis 12 Radix Astragali 30 Radix Cyathulae 20 Radix Salviae Miltiorrhizae 10 Scolopendra 10 Pheretima 10 Fructus Chaenomelis 10 Saussurea lappa Clarke 10 Radix Et Rhizoma Rhei 12 Rhizoma Atractylodis Macrocephalae 10 Radix Bupleuri 10 Ramulus Cinnamomi 10 Cortex Eucommiae 15 Radix Glycyrrhizae 10 Massa Medicata Fermentata 8 Caulis Spatholobi 8 Poria 10
Formula 2:
Rhizoma Et Radix Notopterygii 5 Radix Angelicae Pubescentis 5 Radix Clematidis 5 Rhizoma Corydalis 5 Radix Gentianae Macrophyllae 5 Radix Dipsaci 5 Herba Asari 5 Rhizoma Zingiberis 5 Radix Astragali 5 Radix Cyathulae 5 Radix Salviae Miltiorrhizae 5 Scolopendra 5 Pheretima 5 Fructus Chaenomelis 5 Saussurea lappa Clarke 5 Radix Et Rhizoma Rhei 5 Rhizoma Atractylodis Macrocephalae 5 Radix Bupleuri 5 Ramulus Cinnamomi 5 Cortex Eucommiae 5 Radix Glycyrrhizae 5 Massa Medicata Fermentata 5 Caulis Spatholobi 5 Poria 5
Formula 3:
Rhizoma Et Radix Notopterygii 10 Radix Angelicae Pubescentis 10 Radix Clematidis 15 Rhizoma Corydalis 8 Radix Gentianae Macrophyllae 8 Radix Dipsaci 8 Herba Asari 6 Rhizoma Zingiberis 8 Radix Astragali 20 Radix Cyathulae 15 Radix Salviae Miltiorrhizae 8 Scolopendra 8 Pheretima 8 Fructus Chaenomelis 8 Saussurea lappa Clarke 8 Radix Et Rhizoma Rhei 8 Rhizoma Atractylodis Macrocephalae 8 Radix Bupleuri 8 Ramulus Cinnamomi 8 Cortex Eucommiae 10 Radix Glycyrrhizae 10 Massa Medicata Fermentata 6 Caulis Spatholobi 6 Poria 8
Embodiment:
By formula 1 proportioning take raw material (gram):
Rhizoma Et Radix Notopterygii 20 Radix Angelicae Pubescentis 20 Radix Clematidis 25 Rhizoma Corydalis 10
Radix Gentianae Macrophyllae 10 Radix Dipsaci 15 Herba Asari 6 Rhizoma Zingiberiss 12
The Radix Astragali 30 Radix Cyathulae 20 Radix Salviae Miltiorrhizae 10 Scolopendras 10
Pheretima 10 Fructus Chaenomelis 10 Saussurea lappa Clarke 10 Radix Et Rhizoma Rhei 12
The Rhizoma Atractylodis Macrocephalae 10 Radix Bupleuri 10 Ramulus Cinnamomi 10 Cortexs Eucommiae 15
Radix Glycyrrhizae 10 Massa Medicata Fermentata 8 Caulis Spatholobi 8 Poria 10
Production method is: after each component drug in prescription being screened and remove earth, dust, being dried, makes powder, crosses 80 sieves, in ratio mix homogeneously in prescription, incapsulate, and approximately 3.8 grams every, totally 80.
Instructions of taking: per day for adults 2-3 time, each 2-3 grain after meal boiled water clothes send, and within one month, is 1 course for the treatment of, 5 years old-12 years old child every day 2 times each one after meal warm water clothes give.

Claims (4)

1. treat a medicine for rheumatic osteopathia, it is characterized in that it is to be made by the raw material of following weight parts:
Rhizoma Et Radix Notopterygii 5-20 Radix Angelicae Pubescentis 5-20 Radix Clematidis 5-25 Rhizoma Corydalis 5-10
Radix Gentianae Macrophyllae 5-10 Radix Dipsaci 5-15 Herba Asari 5-6 Rhizoma Zingiberis 5-12
Radix Astragali 5-30 Radix Cyathulae 5-20 Radix Salviae Miltiorrhizae 5-10 Scolopendra 5-10
Pheretima 5-10 Fructus Chaenomelis 5-10 Saussurea lappa Clarke 5-10 Radix Et Rhizoma Rhei 5-12
Rhizoma Atractylodis Macrocephalae 5-10 Radix Bupleuri 5-10 Ramulus Cinnamomi 5-10 Cortex Eucommiae 5-15
Radix Glycyrrhizae 5-10 Massa Medicata Fermentata 5-8 Caulis Spatholobi 5-8 Poria 5-10.
2. the medicine for the treatment of rheumatic osteopathia according to claim 1, is characterized in that it is to be made by the raw material of following weight parts:
Rhizoma Et Radix Notopterygii 20 Radix Angelicae Pubescentis 20 Radix Clematidis 25 Rhizoma Corydalis 10
Radix Gentianae Macrophyllae 10 Radix Dipsaci 15 Herba Asari 6 Rhizoma Zingiberiss 12
The Radix Astragali 30 Radix Cyathulae 20 Radix Salviae Miltiorrhizae 10 Scolopendras 10
Pheretima 10 Fructus Chaenomelis 10 Saussurea lappa Clarke 10 Radix Et Rhizoma Rhei 12
The Rhizoma Atractylodis Macrocephalae 10 Radix Bupleuri 10 Ramulus Cinnamomi 10 Cortexs Eucommiae 15
Radix Glycyrrhizae 10 Massa Medicata Fermentata 8 Caulis Spatholobi 8 Poria 10.
3. the medicine for the treatment of rheumatic osteopathia according to claim 1 and 2, is characterized in that said medicine is said dosage form on any pharmaceutics.
4. the medicine for the treatment of rheumatic osteopathia according to claim 3, is characterized in that said medicament is powder or piece agent.
CN201410255761.1A 2014-06-11 2014-06-11 Medicine for treating rheumatoid bone diseases Pending CN104027764A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410255761.1A CN104027764A (en) 2014-06-11 2014-06-11 Medicine for treating rheumatoid bone diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410255761.1A CN104027764A (en) 2014-06-11 2014-06-11 Medicine for treating rheumatoid bone diseases

Publications (1)

Publication Number Publication Date
CN104027764A true CN104027764A (en) 2014-09-10

Family

ID=51458908

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410255761.1A Pending CN104027764A (en) 2014-06-11 2014-06-11 Medicine for treating rheumatoid bone diseases

Country Status (1)

Country Link
CN (1) CN104027764A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105311210A (en) * 2015-12-02 2016-02-10 隋妍蕾 Pharmaceutical composition for treating rheumatoid bone diseases
CN105920570A (en) * 2016-07-04 2016-09-07 李布仁贺喜格 External application traditional Chinese medicine for quickly treating rheumatic bone diseases and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1375326A (en) * 2002-04-01 2002-10-23 袁锦乾 Traditional Chinese medicine formula for treating wind-cold-dampness diseases

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1375326A (en) * 2002-04-01 2002-10-23 袁锦乾 Traditional Chinese medicine formula for treating wind-cold-dampness diseases

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105311210A (en) * 2015-12-02 2016-02-10 隋妍蕾 Pharmaceutical composition for treating rheumatoid bone diseases
CN105920570A (en) * 2016-07-04 2016-09-07 李布仁贺喜格 External application traditional Chinese medicine for quickly treating rheumatic bone diseases and preparation method thereof

Similar Documents

Publication Publication Date Title
CN100402066C (en) Plaster for treating rheumatism and osteoarthrosis
CN100488549C (en) Externally applied medicament for treating rheumatism
CN101972443B (en) Chinese medicinal formula for treating chronic gastritis
CN102048893B (en) Traditional Chinese medicine composition for treating arthromyodynia
CN103536777B (en) Traditional Chinese medicinal composition for treating knee osteoarthritis
CN102048900A (en) Traditional Chinese medicine preparation for treating lumbar intervertebral disc protrusion
CN104225508A (en) Traditional Chinese medicine composition for cervical spondylosis treatment and preparation method thereof
CN103316298A (en) Traditional Chinese composition for treating arthralgia
CN101966238A (en) Medicament for treating sciatica and preparation method thereof
CN104524159A (en) Pharmaceutical composition for treating hyperplasia of mammary glands
CN101579503B (en) Traditional Chinese medicine for treating rheumatism
CN104258366A (en) Traditional Chinese medicine preparation for lumbago and preparation method thereof
CN103316296B (en) Traditional Chinese medicine composition for treating hyperostosis
CN103041271B (en) Traditional Chinese medicine composition for treating emphysema
CN104027764A (en) Medicine for treating rheumatoid bone diseases
CN101690797B (en) Traditional Chinese medicine for treating rheumatism and rheumatoid diseases
CN104523873A (en) Pharmaceutical composition for treating gout
CN103989999A (en) Traditional Chinese medicinal preparation for treating spinal tuberculosis and preparation method thereof
CN102579672A (en) Medicament for treating bone hyperplasia and lumbar disc herniation
CN102949698A (en) Medicine for treating uterine myoma and preparation method thereof
CN106511905A (en) Traditional Chinese medicine preparation used for curing cervical spondylosis and preparation method thereof
CN104771657A (en) Traditional Chinese medicine composition for treating gastric ulcer
CN104173934A (en) Traditional Chinese medicine composition for treating sciatica
CN103041362A (en) Drug for treating rheumatism and rheumatoid and preparation method thereof
CN103169876A (en) Chinese medicament composition for treating arthralgia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20140910

RJ01 Rejection of invention patent application after publication